SHOview Observational Study. Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2014
At a glance
- Drugs Menotropin (Primary)
- Indications Female infertility
- Focus Adverse reactions
- Acronyms SHOview
- Sponsors Ferring Pharmaceuticals
- 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jun 2014.
- 10 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.